Actively Recruiting

Phase Not Applicable
Age: 50Years +
All Genders
Healthy Volunteers
ID05373043

Evaluating the Long-term Health Consequences of COVID-19 and Rehabilitation Therapies to Speed Convalescence

Led by VA Office of Research and Development · Updated on 2025-09-18

300

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to evaluate the long-term effects of COVID-19 on vascular endothelial function and overall health in older Veterans, including those experiencing long-COVID symptoms such as fatigue, weakness, and cognitive difficulties. The study focuses on understanding how oxidative stress and inflammation caused by aging and COVID-19 impact vascular health and recovery, with the goal of improving rehabilitation strategies to reduce health risks and enhance recovery outcomes. Participants will be assigned to one of two groups: exercise-based rehabilitation combined with a mitochondria-targeted antioxidant supplement called Mito-Q, or exercise-based rehabilitation with a placebo. These interventions are designed to improve vascular function by reducing oxidative stress and inflammation. The study includes a 4-year observation period with tests conducted twice annually to assess vascular health and the effectiveness of the rehabilitation approaches. Throughout the study, participants will undergo assessments of vascular endothelial function using several tests, including flow-mediated dilation, passive leg movement, and breath-hold acceleration index, at baseline and multiple follow-up times up to 4 years. Researchers will also monitor neurocognitive and pulmonary function, along with overall health risks and outcomes. The study involves regular evaluations to track progress and safety, aiming to provide clear recommendations for rehabilitation in older Veterans recovering from COVID-19 and those without COVID-19 history.

CONDITIONS

Brief Title

Long-term COVID and Rehabilitation

Who Can Participate

Age: 50Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • 50 years of age or greater
  • Long-COVID and COVID-recovered patients must have a positive SARS-CoV-2 test near the time of COVID-19 diagnosis
  • Long-COVID and COVID-recovered patients must be 3 to 12 months post-initial COVID-19 diagnosis
  • Ability to sign informed consent
Not Eligible

You will not qualify if you...

  • Body mass index greater than 45 kg/m2
  • Unstable (less than 6 months) or severe coronary artery disease (CAD-RADS score = 4A)
  • Peripheral artery disease (Ankle Brachial Index less than 0.40)
  • Cerebrovascular disease (stroke in the last 12 months)
  • Severe chronic obstructive pulmonary disease (Stage III)
  • Uncontrolled hypertension (greater than 160/100 mmHg)
  • Chronic kidney disease requiring dialysis
  • Severe renal insufficiency (creatinine clearance less than 30 by Cockcroft-Gault formula)
  • Alzheimer's disease or dementia
  • Orthopedic limitations preventing exercise
  • Current smokers or those who stopped smoking within the last 10 years
  • Currently taking Mito-Q or unwilling to stop dietary supplements for participation
  • Any other condition or event considered exclusionary by the principal investigators or a physician

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 6 months

Participants receive exercise-based rehabilitation with either Mito-Q supplementation or placebo to improve vascular endothelial function.

Visits at baseline, month 3, and month 6

Long-term Monitoring

Duration - Up to 4 years

Participants are assessed every 6 months for up to 4 years to evaluate long-term vascular endothelial function and health outcomes after rehabilitation.

Visits every 6 months after month 6 until year 4

Trial Site Locations

Total: 1 location

1

VA Salt Lake City Health Care System, Salt Lake City, UT

Salt Lake City, Utah, United States, 84148-0001

Actively Recruiting

Loading map...

Research Team

J

Joel D Trinity, PhD

R

Russell S Richardson, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here